Complete response for advanced liver cancer during sorafenib therapy: case report (Q33795187)

29 July 2017

Complete response for advanced liver cancer during sorafenib therapy: case report (English)

1 reference

29 July 2017

1 reference

Rodolfo Sacco

1

1 reference

29 July 2017

Irene Bargellini

2

1 reference

29 July 2017

Giannelli Gianluigi

3

1 reference

29 July 2017

Marco Bertini

4

1 reference

29 July 2017

Elena Bozzi

5

1 reference

29 July 2017

Emanuele Altomare

6

1 reference

29 July 2017

Valentina Battaglia

7

1 reference

29 July 2017

Antonio Romano

8

1 reference

29 July 2017

Michele Bertoni

9

1 reference

29 July 2017

Alfonso Capria

10

1 reference

29 July 2017

Giampaolo Bresci

11

1 reference

29 July 2017

Carlo Bartolozzi

12

1 reference

29 July 2017

17 January 2011

1 reference

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

4

1 reference

Creative Commons Attribution 2.0 Generic

29 July 2017

start time

17 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-230x-11-4

0 references

cites work

CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Pathological complete remission of advanced hepatocellular carcinoma with main portal vein tumor thrombosis by hepatic arterial infusion chemotherapy.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Experience with sorafenib and the elderly patient

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Sorafenib in advanced hepatocellular carcinoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Design and endpoints of clinical trials in hepatocellular carcinoma.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Systemic therapy for advanced hepatocellular carcinoma: a review.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Estimating the world cancer burden: Globocan 2000.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-4

The mysterious case of spontaneous disappearance of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-4

Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-4

Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036648

A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-11-4

Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21241463

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21241463

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Liver transplantation for hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21241463

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-230X-11-4

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference